Carnegie Lake Advisors’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$794K Hold
16,794
0.3% 81
2026
Q1
$995K Sell
16,794
-980
-6% -$63.6K 0.4% 63
2025
Q4
$1.1M Sell
17,774
-1,500
-8% -$91.8K 0.42% 59
2025
Q3
$1.2M Buy
19,274
+5,210
+37% +$363K 0.46% 56
2025
Q2
$1.12M Sell
14,064
-100
-0.7% -$8.36K 0.44% 62
2025
Q1
$1.22M Sell
14,164
-236
-2% -$19.4K 0.49% 58
2024
Q4
$1.12M Hold
14,400
0.45% 60
2024
Q3
$1.04M Buy
+14,400
New +$1.02M 0.41% 65

Other funds holding PBH

Carnegie Lake Advisors's PBH Position: Q2 2026 in Review

Carnegie Lake Advisors held its Prestige Consumer Healthcare (PBH) position steady in Q2 2026 at 16,794 shares worth $794K. The position accounts for 0.3% of the portfolio, ranked #81.

Carnegie Lake Advisors first reported a position in PBH in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.22M in Q1 2025. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Carnegie Lake Advisors held 16,794 shares of Prestige Consumer Healthcare worth $794K as of Q2 2026.
  • Carnegie Lake Advisors left its Prestige Consumer Healthcare share count unchanged in Q2 2026.
  • Prestige Consumer Healthcare made up 0.3% of Carnegie Lake Advisors's portfolio in Q2 2026, its #81 holding.
  • Carnegie Lake Advisors first reported a position in Prestige Consumer Healthcare in Q3 2024 and has held it in 8 quarters since.
  • Carnegie Lake Advisors's Prestige Consumer Healthcare position peaked at $1.22M in Q1 2025.
  • 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Carnegie Lake Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.